QualityStocks would like to highlight Tegal Corporation (NASDAQ: TGAL), dedicated to the development and application of emerging technologies. For 40 years, Tegal’s process and equipment know-how has been incorporated in devices fabricated by some of the world’s leading semiconductor and MEMS companies, including Tegal’s one-time parent, Motorola. Now entering its fifth decade, Tegal has committed its future to emerging technologies in medical devices and health care.
In the company’s news yesterday,
Tegal announced that it expects to appoint James Karis as Co-CEO of Tegal and also a director of the firm. The appointment will effective upon completion of the deal to acquire CollabRx Inc., where Mr. Karis serves as CEO and director. CollabRx is a privately-held technology company in the rapidly growing market of interpretive content and data analytics for genomics-based medicine with a particular focus on cancer.
Mr. Karis, who became CollabRx CEO in 2011, served for nine years as president and CEO of Entelos, a US-based life sciences technology company. Prior to that, he held a number of important senior positions at several companies, including president and chief operating officer of PAREXEL International, COO of Pharmaco International, and vice-president of international operations at Baxter International. Mr. Karis also co-founded KMR Group, a leading pharmaceutical research and development benchmarking consulting firm.
The incoming Mr. Karis will join Tegal’s chairman, president, and current CEO Thomas Mika in the Co-CEO role. Upon completion of the transaction and following Tegal’s annual meeting in September, the combined company will conduct business under the CollabRx name.
QualityStocks, based in Scottsdale, Arizona, is a free service that collects data from hundreds of Small-Cap and Micro-Cap online Investment Newsletters into one Daily Newsletter Report. QualityStocks is dedicated to assisting emerging public companies with their investor communication efforts and connecting subscribers with companies that have huge potential to succeed in the short and long-term future.
To sign up for The QualityStocks Daily Newsletter, please visit www.QualityStocks.net
Please read FULL disclaimer on the QualityStocks website: http://Disclaimer.QualityStocks.net
This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Risks and uncertainties applicable to the company and its business could cause the company's actual results to differ materially from those indicated in any forward-looking statements.